Harvard Bioscience
Thomas Loewald was appointed a Director of the Company on October 24, 2017 and is Chair of the Compensation Committee and a member of the Governance Committee and the Audit Committee. In September, 2020, Mr. Loewald joined Cambrex, a leading private equity-owned Contract Development & Manufacturing Organization, as President and CEO.
Previously, Mr. Loewald served as President of the Flexibles Division of ProAmpac, a leading flexible packaging manufacturer. Prior to ProAmpac, he served as Senior Vice President and Chief Commercial Officer at Thermo Fisher Scientific, a recognized world leader in serving science and a highly effective industry consolidator, as well as Group President of the $1.6 B Laboratory Products Group. In his role as CCO, he was responsible for designing and leading Thermo Fisher’s commercial strategy and enterprise-spanning commercial resources. During a 14-year tenure with Thermo Fisher, Mr. Loewald played a key role in helping the company expand from a $3 B to a $20 B company. He had also served as the SVP and President of the company’s $3.7 B Analytical Instruments Group, held two Division President roles and was VP of Sales and Services for the Environmental Instruments Division. Earlier in his career, Mr. Loewald led sales, marketing, and customer service for the $400 MM adhesives division of Tyco International. Prior to Tyco, he held a series of roles with General Electric’s Plastics and Materials businesses.
This person is not in the org chart
This person is not in any teams
This person is not in any offices